Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Horizon inks supply and licensing deal with Adarza
January 2015
by  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

CAMBRIDGE, U.K & ST. LOUIS—An exclusive license and supply agreement was announced between Horizon Discovery Group plc and Adarza BioSystems Inc. that grants Horizon the exclusive right to supply services on Adarza’s multiplex immunoassay technology, Arrayed Imaging Reflectometry. Under this agreement, Horizon has exclusive rights to offer research services using Adarza’s platform, and next year, Horizon will launch a portfolio of products that can detect between 100 and 400 analytes and will offer custom assay development on the platform.
 
“We are delighted to be working with one of the world’s fastest-growing life-science companies dedicated to driving forward the fields of gene editing and translational genomics. The agreement with Horizon validates Adarza’s disruptive technology platform and allows us to leverage Horizon’s world-class sales and marketing network to bring the technology to market sooner and much more broadly than we could alone,” said Dr. Preston Keller, Adarza’s vice president of business development.
 
Code:

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.